Inhibition of the STAT3 target SGK1 sensitizes diffuse large B cell lymphoma cells to AKT inhibitors.

导出 OA

翻译打印收藏纠错

作者： Li,Lu ^[1] ; Fen,Zhu ^[2] ; Yangguang,Li ^[1] ; Shuichi,Kimpara ^[2] ; Nguyet Minh,Hoang ^[1] ; Sheida,Pourdashti ^[2] ; Lixin,Rui ^[1]

作者单位： Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI, 53726, USA. ^[1] Carbone Cancer Center, University of Wisconsin School of Medicine and Public Health, Madison, WI, 53726, USA. ^[2] Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI, 53726, USA. lrui@medicine.wisc.edu. ^[3] Carbone Cancer Center, University of Wisconsin School of Medicine and Public Health, Madison, WI, 53726, USA. lrui@medicine.wisc.edu. ^[4]

主题词人类(Humans);淋巴瘤, 大B细胞, 弥漫性(Lymphoma, Large B-Cell, Diffuse);蛋白激酶抑制剂(Protein Kinase Inhibitors);STAT3转录因子(STAT3 Transcription Factor)

DOI 10.1038/s41408-019-0203-y

PMID 30926771

发布时间 2021-01-09

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交